Novel immunotherapies in multiple myeloma: chances and challenges

In this review article, we summarize the latest data on antibody-drug conjugates, bispecific T-cell-engaging antibodies, and chimeric antigen receptor T cells in the treatment of multiple myeloma. We discuss the pivotal questions to be addressed as these new immunotherapies become standard agents in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rasche, Leo (VerfasserIn) , Wäsch, Ralph (VerfasserIn) , Munder, Markus (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Raab, Marc-Steffen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 1, 2021
In: Haematologica
Year: 2021, Jahrgang: 106, Heft: 10, Pages: 2555-2565
ISSN:1592-8721
DOI:10.3324/haematol.2020.266858
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/haematol.2020.266858
Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/haematol.2020.266858
Volltext
Verfasserangaben:Leo Rasche, Ralph Wäsch, Markus Munder, Hartmut Goldschmidt and Marc S. Raab

MARC

LEADER 00000caa a2200000 c 4500
001 1788617878
003 DE-627
005 20230426162751.0
007 cr uuu---uuuuu
008 220204s2021 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2020.266858  |2 doi 
035 |a (DE-627)1788617878 
035 |a (DE-599)KXP1788617878 
035 |a (OCoLC)1341439556 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rasche, Leo  |d 1980-  |e VerfasserIn  |0 (DE-588)138509298  |0 (DE-627)603782507  |0 (DE-576)307868362  |4 aut 
245 1 0 |a Novel immunotherapies in multiple myeloma  |b chances and challenges  |c Leo Rasche, Ralph Wäsch, Markus Munder, Hartmut Goldschmidt and Marc S. Raab 
264 1 |c July 1, 2021 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.02.2022 
520 |a In this review article, we summarize the latest data on antibody-drug conjugates, bispecific T-cell-engaging antibodies, and chimeric antigen receptor T cells in the treatment of multiple myeloma. We discuss the pivotal questions to be addressed as these new immunotherapies become standard agents in the management of multiple myeloma. We also focus on the selection of patients for these therapies and speculate as to how best to individualize treatment approaches. We see these novel immunotherapies as representing a paradigm shift. However, despite the promising preliminary data, many open issues remain to be evaluated in future trials. 
700 1 |a Wäsch, Ralph  |d 1965-  |e VerfasserIn  |0 (DE-588)118204807  |0 (DE-627)079304893  |0 (DE-576)291768458  |4 aut 
700 1 |a Munder, Markus  |d 1967-  |e VerfasserIn  |0 (DE-588)121183610  |0 (DE-627)705288188  |0 (DE-576)292574347  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Raab, Marc-Steffen  |d 1973-  |e VerfasserIn  |0 (DE-588)124052460  |0 (DE-627)706520998  |0 (DE-576)293998027  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 106(2021), 10, Seite 2555-2565  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Novel immunotherapies in multiple myeloma chances and challenges 
773 1 8 |g volume:106  |g year:2021  |g number:10  |g pages:2555-2565  |g extent:11  |a Novel immunotherapies in multiple myeloma chances and challenges 
856 4 0 |u https://doi.org/10.3324/haematol.2020.266858  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://haematologica.org/article/view/haematol.2020.266858  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220204 
993 |a Article 
994 |a 2021 
998 |g 124052460  |a Raab, Marc-Steffen  |m 124052460:Raab, Marc-Steffen  |d 910000  |d 910100  |e 910000PR124052460  |e 910100PR124052460  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1788617878  |e 4051396223 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"July 1, 2021","dateIssuedKey":"2021"}],"note":["Gesehen am 04.02.2022"],"title":[{"title_sort":"Novel immunotherapies in multiple myeloma","subtitle":"chances and challenges","title":"Novel immunotherapies in multiple myeloma"}],"id":{"eki":["1788617878"],"doi":["10.3324/haematol.2020.266858"]},"name":{"displayForm":["Leo Rasche, Ralph Wäsch, Markus Munder, Hartmut Goldschmidt and Marc S. Raab"]},"physDesc":[{"extent":"11 S."}],"relHost":[{"language":["eng"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"part":{"pages":"2555-2565","year":"2021","issue":"10","text":"106(2021), 10, Seite 2555-2565","volume":"106","extent":"11"},"origin":[{"publisherPlace":"Pavia","dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisher":"Ferrata Storti Foundation"}],"note":["Gesehen am 27.05.2022"],"pubHistory":["99.2014 -"],"title":[{"subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title_sort":"Haematologica","title":"Haematologica"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Novel immunotherapies in multiple myeloma chances and challengesHaematologica","physDesc":[{"extent":"Online-Ressource"}],"recId":"814204899","id":{"eki":["814204899"],"zdb":["2805244-4"],"issn":["1592-8721"]}}],"recId":"1788617878","person":[{"display":"Rasche, Leo","family":"Rasche","given":"Leo","role":"aut"},{"given":"Ralph","role":"aut","display":"Wäsch, Ralph","family":"Wäsch"},{"given":"Markus","role":"aut","family":"Munder","display":"Munder, Markus"},{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"given":"Marc-Steffen","role":"aut","display":"Raab, Marc-Steffen","family":"Raab"}],"language":["eng"]} 
SRT |a RASCHELEOWNOVELIMMUN1202